Adropin and risk factors of arterial hypertension in patients with excess body weight and obesity
Introduction. Adropin is a hormone that is involved in the pathogenesis of arterial hypertension (AH) and diseases of the cardiovascular system and energy homeostasis, in particular, it reduces insulin resistance by controlling glucose synthesis in the liver. Aim. To investigate the level of adropin...
Main Authors: | Nataliia Pokrovska, Eugen Sklyarov |
---|---|
Format: | Article |
Language: | English |
Published: |
V. N. Karazin Kharkiv National University
2022-11-01
|
Series: | Journal of V. N. Karazin Kharkiv National University: Series Medicine |
Subjects: | |
Online Access: | https://periodicals.karazin.ua/medicine/article/view/21062 |
Similar Items
-
Beneficial effects of statins on adropin level in patients with arterial hypertension
by: N.K. Pokrovska, et al.
Published: (2023-02-01) -
Adropin as an indicator of T2DM and its complications
by: Hu Zhang, et al.
Published: (2022-11-01) -
An association between adropin hormone and total testosterone in obese men: a case-control study
by: Asmaa A. Muhammed, et al.
Published: (2022-07-01) -
Negative association between serum adropin and hypertensive disorders complicating pregnancy
by: Dong Lin, et al.
Published: (2019-10-01) -
Association between serum adropin levels and isolated coronary artery ectasia in patients with stable angina pectoris
by: Buğra Özkan, et al.
Published: (2019-11-01)